- Home
- OPHC vs ANVS Comparison
OPHC vs ANVS Comparison
Compare OPHC & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPHC
- ANVS
- Stock Information
- Founded
- OPHC 2000
- ANVS 2008
- Country
- OPHC United States
- ANVS United States
- Employees
- OPHC N/A
- ANVS 6
- Industry
- OPHC Major Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- OPHC Finance
- ANVS Health Care
- Exchange
- OPHC Nasdaq
- ANVS Nasdaq
- Market Cap
- OPHC 51.8M
- ANVS 44.6M
- IPO Year
- OPHC N/A
- ANVS 2020
- Fundamental
- Price
- OPHC $4.52
- ANVS $2.38
- Analyst Decision
- OPHC
- ANVS Strong Buy
- Analyst Count
- OPHC 0
- ANVS 5
- Target Price
- OPHC N/A
- ANVS $30.25
- AVG Volume (30 Days)
- OPHC 8.2K
- ANVS 607.7K
- Earning Date
- OPHC 08-05-2025
- ANVS 08-14-2025
- Dividend Yield
- OPHC N/A
- ANVS N/A
- EPS Growth
- OPHC 30.24
- ANVS N/A
- EPS
- OPHC 1.33
- ANVS N/A
- Revenue
- OPHC $39,980,000.00
- ANVS N/A
- Revenue This Year
- OPHC N/A
- ANVS N/A
- Revenue Next Year
- OPHC N/A
- ANVS N/A
- P/E Ratio
- OPHC $3.37
- ANVS N/A
- Revenue Growth
- OPHC 53.28
- ANVS N/A
- 52 Week Low
- OPHC $3.53
- ANVS $1.11
- 52 Week High
- OPHC $5.90
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- OPHC 56.95
- ANVS 48.74
- Support Level
- OPHC $4.42
- ANVS $2.05
- Resistance Level
- OPHC $4.62
- ANVS $3.18
- Average True Range (ATR)
- OPHC 0.06
- ANVS 0.27
- MACD
- OPHC 0.01
- ANVS -0.09
- Stochastic Oscillator
- OPHC 61.54
- ANVS 29.20
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.